methyl 4-(biphenyl-4-yl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate | 294198-00-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: methyl 4-(biphenyl-4-yl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate
• 英文别名: methyl 2,7,7-trimethyl-5-oxo-4-(4-phenylphenyl)-1,4,6,7,8-pentahydroquinoline-3-carboxylate；methyl 2,7,7-trimethyl-5-oxo-4-(4-phenylphenyl)-1,4,6,8-tetrahydroquinoline-3-carboxylate
• CAS: 294198-00-8
• 化学式: C₂₆H₂₇NO₃
• 分子量: 401.505
• InChiKey: JRJFPGTYRGVBGA-UHFFFAOYSA-N

物化性质

• 沸点：
  560.0±50.0 °C(Predicted)
• 密度：
  1.19±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.9
• 重原子数：
  30
• 可旋转键数：
  4
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.31
• 拓扑面积：
  55.4
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  methyl 4-(biphenyl-4-yl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate 在 三氯化硼 作用下， 以 二氯甲烷 为溶剂， 以75%的产率得到4-(biphenyl-4-yl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylic acid
  参考文献：
  名称：

  Synthesis and SAR of b-Annulated 1,4-Dihydropyridines Define Cardiomyogenic Compounds as Novel Inhibitors of TGFβ Signaling

  摘要：

  A medium-throughput murine embryonic stem cell (mESC)-based high-content screening of 17000 small molecules for cardiogenesis led to the identification of a b-annulated 1,4-dihydropyridine (1,4-DHP) that inhibited transforming growth factor beta (TGF beta)/Smad signaling by clearing the type II TGF beta receptor from the cell surface. Because this is an unprecedented mechanism of action, we explored the series' structure-activity relationship (SAR) based on TGF beta inhibition, and evaluated SAR aspects for cell-surface clearance of TGF beta receptor II (TGFBR2) and for biological activity in mESCs. We determined a pharmacophore and generated 1,4-DHPs with IC(50)s for TGF beta inhibition in the nanomolar range (e.g., compound. 28, 170 nM). Stereochemical consequences of a chiral center at the 4-position was evaluated, revealing 10- to 15-fold more potent TGF beta inhibition for the (+)- than the (-) enantiomer. This stereopreference was not observed for the low level inhibition against Activin A signaling and was reversed for effects on calcium handling in HL-1 cells.

  DOI：

  10.1021/jm301144g
• 作为产物：
  描述：

  5,5-二甲基-1,3-环己二酮 、 乙酰乙酸甲酯 、 对苯基苯甲醛 在 ammonium acetate 作用下， 以 水 为溶剂， 反应 0.5h， 以90%的产率得到methyl 4-(biphenyl-4-yl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate
  参考文献：
  名称：

  One-pot multicomponent synthesis hexahydroquinoline derivatives in Triton X-100 aqueous micellar media

  摘要：

  简述 在室温下，在水溶剂 Triton X-100 的存在下，通过醛、二甲基酮、乙酰乙酸甲酯和乙酸铵的四组分缩合反应，简便高效地合成了六氢喹啉衍生物 (5a-o)。在水溶剂中只需使用 20 摩尔 % 的 Triton X-100 即可。傅立叶变换红外光谱、19F NMR、1H NMR、13C NMR 光谱和元素分析证实了这些化合物的结构。

  DOI：

  10.1016/j.crci.2012.11.017

文献信息

• Synthesis of the first nano ionic liquid 1-methylimidazolium trinitromethanide {[HMIM]C(NO₂)₃} and its catalytic use for Hanztsch four-component condensation
  作者：Mohammad Ali Zolfigol、Saeed Baghery、Ahmad Reza Moosavi-Zare、Seyed Mohammad Vahdat、Heshmatollah Alinezhad、Mohammad Norouzi

  DOI：10.1039/c4ra09117e

  日期：——

  A novel, green and reusable nano ionic liquid and catalyst, namely 1-methylimidazolium trinitromethanide [HMIM]C(NO2)3}, was designed and fully characterized by 1H NMR, 13C NMR, IR, mass, X-ray diffraction patterns (XRD) and Transmission electron microscopy (TEM) analysis. The catalytic application of the presented catalyst was successfully tested on the Hantzsch four-component reaction of various aromatic aldehydes, 1,3-dione, β-ketoester and ammonium acetate at room temperature under solvent-free and mild conditions to give the polyhydroquinoline derivatives in good to excellent yields. In the presented work, some products have been reported for the first time.

  设计并全面表征了一种新颖、绿色且可重复使用的纳米离子液体及催化剂，即1-甲基咪唑三硝基甲烷盐[HMIM]C(NO2)3}，通过1H NMR、13C NMR、IR、质谱、X射线衍射图谱(XRD)和透射电子显微镜(TEM)分析进行了表征。该催化剂在室温下、无溶剂和温和条件下成功应用于Hantzsch四组分反应，涉及各种芳香醛、1,3-二酮、β-酮酯和乙酸铵，得到了产率良好的多氢喹啉衍生物。在本文中，首次报道了一些产物。
• One-pot multicomponent synthesis hexahydroquinoline derivatives in Triton X-100 aqueous micellar media
  作者：Mohammad Reza Poor Heravi、Shadi Mehranfar、Nemat Shabani

  DOI：10.1016/j.crci.2012.11.017

  日期：2014.2

  Résumé A facile and efficient synthesis of hexahydroquinoline derivatives (5a–o) was reported via a four-component condensation reaction of aldehydes, dimedone, methyl aceto acetate and ammonium acetate in the presence of Triton X-100 in water at room temperature. The use of just 20 mol % of Triton X-100 in water solvent is sufficient. The FT-IR, 19F NMR, 1H NMR, 13C NMR spectra and elemental analysis confirm the structure of the compounds.

  简述 在室温下，在水溶剂 Triton X-100 的存在下，通过醛、二甲基酮、乙酰乙酸甲酯和乙酸铵的四组分缩合反应，简便高效地合成了六氢喹啉衍生物 (5a-o)。在水溶剂中只需使用 20 摩尔 % 的 Triton X-100 即可。傅立叶变换红外光谱、19F NMR、1H NMR、13C NMR 光谱和元素分析证实了这些化合物的结构。
• COMPOUNDS FOR STEM CELL DIFFERENTIATION
  申请人：Mercola Mark

  公开号：US20110281356A1

  公开（公告）日：2011-11-17

  Methods and small molecule compounds for stem cell differentiation are provided. One example of a class of compounds that may be used is represented by the compound of Formula I: or a pharmaceutically acceptable salt or solvate thereof, wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 5′ , R 6 , R 6′ , R 7 , R 7′ are as described herein.

  提供了用于干细胞分化的方法和小分子化合物。可以使用的化合物类别之一的示例由公式I所表示的化合物组成：或其药学上可接受的盐或溶剂，其中R1，R2，R3，R4，R5，R5'，R6，R6'，R7，R7'如本文所述。
• SMALL MOLECULE COMPOUNDS FOR STEM CELL DIFFERENTIATION
  申请人：Mercola Mark

  公开号：US20100159596A1

  公开（公告）日：2010-06-24

  Methods and small molecule compounds for stem cell differentiation are provided. One example of a class of compounds that may be used is represented by the compound having the structure IA or IB in the form of free base or a pharmaceutically acceptable salt, hydrate, solvate or N-oxide thereof: R 1 is independently hydrogen or (C 1 -C 6 )alkyl; R 2 is independently hydrogen, (C 1 -C 6 )alkyl, aryl, or heteroaryl; R 2′ is independently hydrogen, (C 1 -C 6 )alkyl, CF 3 or C 2 F 5 ; R 3 is independently (C 1 -C 6 )alkyl, aryl, 2-tetrahydrofurylmethyl, an aliphatic tertiary amine, or 4-methoxybenzyl; or R 2 and R 3 may be joined together to form a 5 or 6 member ring lactone; R 4 is independently hydrogen, (C 1 -C 6 )alkyl, a 2- or 4-R 5 -substituted aromatic ring selected from a 4-R 5 -phenyl or a 2-R 5 -5-pyridyl, aryl, heteroaryl, aliphatic tertiary amine or halogen; and R 5 , R 5′ , R 6 , R 6′ , R 7 , R 7′ , are each independently hydrogen, (C 1 -C 6 )alkyl, aryl, optionally substituted phenyl, heteroaryl, a heterocyclic ring, an aliphatic tertiary amine, or halogen.

  提供干细胞分化的方法和小分子化合物。可以使用的一类化合物的一个示例由结构IA或IB表示，以自由碱基或其药学上可接受的盐，水合物，溶剂或N-氧化物的形式存在：R1独立地是氢或（C1-C6）烷基; R2独立地是氢，（C1-C6）烷基，芳基或杂环芳基; R2'独立地是氢，（C1-C6）烷基，CF3或C2F5; R3独立地是（C1-C6）烷基，芳基，2-四氢呋喃甲基，脂肪族三级胺或4-甲氧基苄基; 或者R2和R3可以结合形成5或6元环内酯; R4独立地是氢，（C1-C6）烷基，2-或4-R5-取代的芳环，选自4-R5-苯基或2-R5-5-吡啶基，芳基，杂环芳基，脂肪族三级胺或卤素; R5，R5'，R6，R6'，R7，R7'独立地是氢，（C1-C6）烷基，芳基，可选取代的苯基，杂环芳基，杂环环，脂肪族三级胺或卤素。
• POLYHYDROQUINOLINE COMPOUNDS AND DIHYDROPYRIDINE COMPOUNDS FOR INHIBITING BETA-AMYLOID PRODUCTION
  申请人：Mullan Michael J.

  公开号：US20100119599A1

  公开（公告）日：2010-05-13

  Provided are methods of treating or reducing the risk of developing beta-amyloid production, beta-amyloid deposition, beta-amyloid neurotoxicity (including abnormal hyperphosphorylation of tau) and microgliosis associated with cerebral accumulation of Alzheimer's amyloid by administering therapeutically effective amounts of polyhydroquinoline and dihydropyridine compounds which decrease Abeta production in cells. Further provided are methods for diagnosing diseases associated with cerebral accumulation of Alzheimer's amyloid in animals or humans by administering diagnostically effective amounts of polyhydroquinoline and dihydropyridine compounds which decrease Abeta production in cells.